OMNI BIO PHARMACEUTICAL, INC.
FORT COLLINS, CO · Founded 2005 · CIK 0001389870 · Biotech · Defunct
Multi-model AI platform for pharmaceutical research and drug discovery
omni.ai →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $28M
- 7 Form D · Mar 2015
- 139 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820092010201120122013
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $20,292,075 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $1,870,000 | |
| Private capital raised | Form D · SEC | $390,000 | |
| Private capital raised | Form D · SEC | $3,079,875 | |
| Private capital raised | Form D · SEC | $687,500 | |
| Private capital raised | Form D · SEC | $1,540,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2834 | Coriell Life Sciences, Inc. | — | $10M |
| 2835 | Tango Therapeutics | — | $95M |
| 2836 | Arcutis Biotherapeutics, Inc. | — | $94M |
| 2837 | OMNI BIO PHARMACEUTICAL, INC. | — | $28M |
| 2838 | ReAlta Life Sciences, Inc. | — | $94M |
| 2839 | Verve Therapeutics | — | $94M |
| 2840 | Scorpion Therapeutics | — | $297M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Vicki BaroneDirector · Executive Officer
- Steven BathgateDirector
- James CrapoDirector · Executive Officer
- Charles DinarelloDirector · Executive Officer
- Michael IsemanDirector
- Michael KamarckDirector
- Brian KlemszDirector
- Albert KramerDirector
- Ed LarkinExecutive Officer
- Edward LarkinExecutive Officer
- Joseph LavignePromoter
- Robert OgdenExecutive Officer
- John RiccardiExecutive Officer
- Bruce SchneiderDirector · Executive Officer
- Rick SeefriedPromoter
- Jeffrey SperberDirector
- Michael WortDirector
- Sandy WrobelDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.